Back
Cellectis SA Vs. Akari Therapeutics PLC Industry Stock Comparison
Buy
62
CLLS
Cellectis SA
Last Price:
1.88
Seasonality Move:
2.21%
Sell
10
AKTX
Akari Therapeutics PLC
Last Price:
1.28
Seasonality Move:
-8.33%
Buy
62
Cellectis SA (CLLS)
is a Buy
Is Cellectis SA a Buy, Sell or Hold?
- The current Cellectis SA [CLLS] share price is $1.91. The Score for CLLS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CLLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
10
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $1.47. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CLLS Stock Price Chart
What is Cellectis SA's stock price today?
-
The Cellectis SA share price today is $1.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $1.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
CLLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.26 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 1.93) | Buy |
| Bollinger Bands (100): | (1.89 - 2.25) | Sell |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 27.4 | Sell |
| Chaikin Money Flow: | -77561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.02 - 2.54) | Sell |
| Bollinger Bands (100): | (2.52 - 3.72) | Sell |
CLLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.93 | Sell |
| 20-day SMA: | 1.86 | Buy |
| 50-day SMA: | 1.99 | Sell |
| 200-day SMA: | 2.36 | Sell |
| 8-day EMA: | 1.91 | Buy |
| 20-day EMA: | 1.9 | Buy |
| 50-day EMA: | 1.97 | Sell |
| 200-day EMA: | 2.24 | Sell |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.06 | Sell |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.66 | Sell |
| 200-day SMA: | 2.54 | Sell |
| 8-day EMA: | 1.97 | Sell |
| 20-day EMA: | 2.23 | Sell |
| 50-day EMA: | 2.57 | Sell |
| 200-day EMA: | 2.95 | Sell |
Cellectis SA Earnings Growth & CLLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Cellectis SA Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||